Trevi Therapeutics

0 followers


Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Industries

Headquarters

Stage

Employees

Links

Org chart

Jennifer Good
Co-Founder, President & CEO

Jennifer Good

Collapse
Thomas Sciascia
Co-Founder, Chief Science Officer
David Clark
Chief Medical Officer
Farrell Simon
Chief Commercial Officer
Katherine Takaki
VP, Global Regulatory Affairs
Angela Hudson Davis, DrPH
Head Quality Assurance and Compliance
Katie McManus
Senior Manager, Marketing & Communications
Paula Buckley
VP, Clinical Operations